4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Comparator: new trials by email Literature Review of Comparator trials Research Report on Comparator
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brivaracetam Bioequivalence Assessment Briveka ® 100 mg, Briviact® 100 mg - Bioequivalence Study in Healthy Subjects | Phase 1 | Completed | Zodiac Produtos Farmaceuticos S.A. | 28 | 2024-08-09 | 2026-09-02 |
| The Safety and Efficacy of MoodElite T-4003-1 on Improving Mood in a Healthy Adult Population With Mild to Moderate Depressive Symptoms Not Eligible for Therapeutic Intervention MoodElite T-4003-1, Comparator, Placebo - Mood | Phase 1 / Phase 2 | Completed | Chenland Nutritionals Inc. | 44 | 2022-03-24 | 2023-03-22 |
| The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers JLP-2002, Comparator - Overactive Bladder(OAB) | Phase 1 | Completed | Jeil Pharmaceutical Co., Ltd. | 42 | 2021-03-13 | 2021-06-14 |
| Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers Treatment 1 (EG-HZ-001), Treatment 2 (EG-HZ-002), Treatment 3 (EG-HZ-003) - Prevention of Herpes Zoster (HZ) | Phase 1 | Completed | EyeGene Inc. | 40 | 2020-02-24 | 2021-02-08 |
Urinary Bladder, Overactive (1)
Chenland Nutritionals Inc. (1) · EyeGene Inc. (1) · Jeil Pharmaceutical Co., Ltd. (1) · Zodiac Produtos Farmaceuticos S.A. (1)
Australia (1) · Brazil (1) · Canada (1) · South Korea (1)